TWD 19.35
(-1.02%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -11.55 Million TWD | -2411.8% |
2022 | 500 Thousand TWD | 106.95% |
2021 | -7.19 Million TWD | -12298.28% |
2020 | -58 Thousand TWD | -100.3% |
2019 | 19.48 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -5.13 Million TWD | -85.46% |
2024 Q2 | -5.13 Million TWD | 0.0% |
2023 Q1 | -3.01 Million TWD | -1284.83% |
2023 Q4 | -2.76 Million TWD | 0.0% |
2023 FY | -11.55 Million TWD | -2411.8% |
2023 Q2 | -3.01 Million TWD | 0.0% |
2023 Q3 | -2.76 Million TWD | 8.12% |
2022 Q4 | -217.5 Thousand TWD | 0.0% |
2022 FY | 500 Thousand TWD | 106.95% |
2022 Q3 | -217.5 Thousand TWD | 0.0% |
2021 FY | -7.19 Million TWD | -12298.28% |
2020 FY | -58 Thousand TWD | -100.3% |
2019 FY | 19.48 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Allied Biotech Corporation | 97.41 Million TWD | 111.866% |
GeneFerm Biotechnology Co., Ltd. | 124.62 Million TWD | 109.275% |
Easywell Biomedicals, Inc. | -144.81 Million TWD | 92.018% |
TTY Biopharm Company Limited | 1.12 Billion TWD | 101.024% |
Synmosa Biopharma Corporation | 594.83 Million TWD | 101.943% |
Orient EuroPharma Co., Ltd. | 143.94 Million TWD | 108.03% |
Center Laboratories, Inc. | -995.42 Million TWD | 98.839% |
Tien Liang BioTech Co., Ltd. | 17.73 Million TWD | 165.187% |
Orient Pharma Co., Ltd. | 22.28 Million TWD | 151.862% |
InnoPharmax Inc. | -70.83 Million TWD | 83.681% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 79.7 Million TWD | 114.503% |
Excelsior Biopharma Inc. | -91.01 Million TWD | 87.299% |
DV Biomed Co., Ltd. | 162.91 Million TWD | 107.095% |
Foresee Pharmaceuticals Co., Ltd. | -1.03 Billion TWD | 98.885% |
Handa Pharmaceuticals, Inc. | 726.88 Million TWD | 101.59% |
UniPharma Co., Ltd. | -21.81 Million TWD | 47.009% |
Anxo Pharmaceutical Co., Ltd. | 21.86 Million TWD | 152.875% |
Alar Pharmaceuticals Inc. | 382.61 Million TWD | 103.021% |
Winston Medical Supply Co., Ltd. | 158.75 Million TWD | 107.281% |
Mercury Biopharmaceutical Corporation | -43.81 Million TWD | 73.619% |
TSH Biopharm Corporation Limited | 61.98 Million TWD | 118.647% |